Jim Breitmeyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jim breitmeyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jim Breitmeyer Today - Breaking & Trending Today

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Carl Byrnes , Salim Yazji , Richard Vincent , Kemp Dolliver , Robert Burns , Jim Breitmeyer , James Breitmeyer , Hartaj Singh , Oncternal Therapeutics Inc , Oppenheimer Company , International Students , Oncternal Therapeutics , Call Transcript May , First Quarter , Chief Financial , Safe Harbor , Private Securities Litigation Reform , Northland Capital , Dangerous Crime Lords , Brookline Capital ,

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Oncternal Therapeutics First Quarter 2023 Financial Results Call. As a reminder, this conference will be recorded. ....

Hartaj Singh , James Breitmeyer , Rosemary Li , Carl Byrnes , Kemp Dolliver , Salim Yazji , Jim Breitmeyer , Richard Vincent , Li Watsek , Oncternal Therapeutics Inc , Cantor Fitzgerald , Oncternal Therapeutics , Call Transcript May , Oncternal Therapeutics First Quarter , Chief Financial , Investor Relations , Private Securities Litigation Reform , Northland Capital , Brookline Capital ,

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2022 Earnings Call Transcript

Operator: Greetings and welcome to the Oncternal Therapeutics, Inc. Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. ....

United States , James Breitmeyer , Hartaj Singh , Jim Breitmeyer , Richard Vincent , Salim Yazji , Oncternal Therapeutics Inc , American Society Of Hematology Annual Meeting , Health Photo , National Institutes Of Health , Oncternal Therapeutics , Call Transcript March , Fourth Quarter , Results Conference , Investor Relations , Private Securities Litigation Reform , American Society , Hematology Annual Meeting , Chief Medical Officer , Olga Guryanova , Rich Vincent , National Institutes , Cap Stocks , Insider Buying , Stocks Under ,

Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript

Oncternal Therapeutics, Inc (NASDAQ:NASDAQ:ONCT) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants James Breitmeyer – President & Chief Executive Officer. ....

United States , Dana Farber Cancer Institute , San Diego , Kumar Raja , Carl Byrnes , James Breitmeyer , Hartaj Singh , Kaveri Pohlman , Shubhendu Sen Roy , Shubhendu Sen Kumar , Jim Breitmeyer , Salim Yazji , Richard Vincent , Vincent Salim Yazji , Brian Petitt , Company Participants , American Society Of Clinical Oncology Meeting , California Institute For Regenerative Medicine , Karolinska Institute , National Institutes Of Health , Oncternal Therapeutics Inc , Oncternal Therapeutics Inc Third Quarter , Uc San Diego School Of Medicine , Oncternal Therapeutics , Conference Call May , Chief Executive ,